Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Institution (Facility)

Also Known As

Dr. Margarete Fischer-Bosch Institut für Klinische Pharmakologie, Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology · Acronym: IKP

2.7K

Publications

444.6K

Citations

282

Authors

548

Concepts

About

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology is a facility institution in Stuttgart, Germany known for medicine, pharmacology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	93	1.3K	105.7K
2	Health Sciences	33	116	10.8K
3	Natural Sciences	27	159	8.6K
4	Engineering	18	73	2.9K
5	Arts	1	2	32

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

2.7K

Publications

444.6K

Citations

Page 1

	Year	Citations
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity <i>in</i> <i>vivo</i> Sven Hoffmeyer, Oliver Burk, Oliver von Richter, Proceedings of the National Academy of Sciences	2000	2.4K
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma Roland Schmitz, George W. Wright, Da Wei Huang, New England Journal of Medicine	2018	2.2K
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes Bjoern Chapuy, Chip Stewart, Andrew Dunford, Nature Medicine Hematological MalignancyLymphoid NeoplasiaMolecular SubtypesImmunologyPathology	2018	1.9K
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma R. Eric Davis, Vu N. Ngo, Georg Lenz, Nature Lymphoid NeoplasiaImmunologyPathologyAdult T-cell Leukemia-lymphomaMedicine	2010	1.6K
Association analysis identifies 65 new breast cancer risk loci Kyriaki Michailidou, Sara Lindström, Joe Dennis, Nature EpidemiologyBreast OncologyCancer RiskEpidemiology Of CancerGenetic Epidemiology	2017	1.5K
Oncogenically active MYD88 mutations in human lymphoma Vu N. Ngo, Ryan M. Young, Roland Schmitz, Nature Tumor BiologyLymphoid NeoplasiaPathologyActive Myd88 MutationsMedicine	2010	1.5K
Metformin improves healthspan and lifespan in mice Alejandro Martín‐Montalvo, Evi M. Mercken, Sarah J. Mitchell, Nature Communications Lifespan ExtensionLongevityMedicinePhysiologyBiogerontology	2013	1.4K
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, The American Journal of Human Genetics	2018	1.1K
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin Bernd Greiner, Michel Eichelbaum, Péter Fritz, Journal of Clinical Investigation	1999	916
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics Roland Schmitz, Ryan M. Young, Michele Ceribelli, Nature Lymphoid NeoplasiaFunctional GenomicsImmunologyTherapeutic TargetsLymphatic System	2012	908

Page 1